The effect of the alpha-2-adrenergic agonist, clonidine, on secretion patterns and rates of adrenocorticotropic hormone and its secretagogues in the horse

Journal of Neuroendocrinology

Volumn 12, Issue 9, 2000, Pages 874-880

  Alexander, S L ^a   Irvine, C H G ^b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b LINCOLN UNIVERSITY   (New Zealand)

Author keywords

ACTH; Alpha 2 adrenoceptors; AVP; Corticotrophin inhibitory factor; CRH

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ARGIPRESSIN; CLONIDINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HORMONE INHIBITOR; HYDROCORTISONE; NEUROHYPOPHYSIS HORMONE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DRUG ACTIVITY; DRUG MECHANISM; FEMALE; HORMONE ACTION; HORMONE INHIBITION; HORSE; MALE; NEUROHYPOPHYSIS; NONHUMAN; PRIORITY JOURNAL; VENOUS BLOOD;

ADRENERGIC ALPHA-AGONISTS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; ARGININE VASOPRESSIN; CLONIDINE; CORTICOTROPIN-RELEASING HORMONE; HORSES; HUMANS; HYDROCORTISONE; KINETICS; MALE; PITUITARY GLAND; RECEPTORS, ADRENERGIC, ALPHA-2; VEINS;

EID: 0033845351     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.2000.00542.x     Document Type: Article

References (51)

1. Yohimbine: A pharmacological probe for study of the α2-adrenoreceptor
2. Diurnal rhythm of α2-noradrenergic receptors in the paraventricular nucleus and other brain areas: Relation to circulating corticosterone and feeding behavior
3. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion
4. The role of alpha-2-adrenoceptors in the control of ACTH secretion: Interaction with the opioid system
5. Adrenergic control of the secretion of anterior pituitary hormones
6. Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in man
7. Vasopressin mediates α1-adrenergic stimulation of adrenocorticotropin secretion
8. Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses
9. Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection
10. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation, potential involvement in the Pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa
11. Factors from the paraventricular nucleus mediate inhibitory effect of alpha-2-adrenergic drugs on ACTH secretion
12. The hunt for the CIA. Factors which demonstrate corticotrophin-inhibitory activity
13. Evidence that the hypothalamus exerts both stimulatory and inhibitory influences over adrenocorticotropin secretion and biosynthesis in the sheep
14. Corticotropin-release inhibitory factor: Evidence for dual stimulatory and inhibitory hypothalamic regulation over adrenocorticotropin secretion and biosynthesis
15. Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis
16. Studies of the regulation of the hypothalamic-pituitary-adrenal axis in sheep with hypothalamic-pituitary disconnection. II. Evidence for in vivo ultradian hypersecretion of proopiomelanocortin peptides by the isolated anterior and intermediate pituitary
17. Comparative chromatography of hypothalamic corticotrophin-releasing factors
18. Dual control of corticotropin secretion: Isolation of corticotropin-inhibiting factor
19. A novel technique for measuring hypothalamic and pituitary hormone secretion rates from collection of pituitary venous effluent in the normal horse
20. Effect of insulin-induced hypoglycaemia on secretion patterns and rates of corticotrophin-releasing hormone, arginine vasopressin and adrenocorticotrophin in horses
21. Sympatho-adrenal activity and the clinical sedative effect of detomidine in horses
22. The effect of acute exercise on the secretion of corticotropin-releasing factor, arginine vasopressin, and adrenocorticotropin as measured in pituitary venous blood from the horse
23. Rapid radioimmunoassay for corticotropin in unextracted human plasma
24. Short-term secretion patterns of corticotropin-releasing hormone, arginine vasopressin and ACTH as shown by intensive sampling of pituitary venous blood from horses
25. The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse
26. Secretory patterns and rates of gonadotropin-releasing hormone, follicle-stimulating hormone, and luteinizing hormone revealed by intensive sampling of pituitary venous blood in the luteal phase mare
27. Kinetics of gonadotrophins in the mare
28. Spontaneous and stimulated adrenocorticotropin and vasopressin pulsatile secretion in the pituitary venous effluent of the horse
29. Clonidin als sedativum beim Pferd
30. A comparison of the sedative effects of three α2-adrenoceptor agonists (romifidine, detomidine and xylazine) in the horse
31. Comparison of the effects of detomidine and xylazine on some α2-adrenoceptor-mediated responses in the central and peripheral nervous systems
32. Factors affecting the circadian rhythm in plasma cortisol concentrations in the horse
33. Decreased secretion of ACTH and cortisol after oral clonidine in normal adults
34. Alpha-2-adrenoceptor agonists stimulate growth hormone secretion but have no acute effects on plasma cortisol under basal conditions
35. Adrenocorticotropin, prolactin and beta-endorphin stimulatory actions of alpha-2-adrenoceptor-antagonists
36. Effect of an osmotic stimulus on the secretion of arginine vasopressin and adrenocorticotropin in the horse
37. Vasopressin and corticotropin-releasing factor: An axonal pathway to portal capillaries in the zona externa of the median eminence containing vasopressin and its interaction with adrenal corticoids
38. Release of oxytocin but not corticotrophin-releasing factor-41 into rat hypophysial portal vessel blood can be made opiate dependent
39. Osmotic inhibition of neurohypophysial secretion
40. Inhibition of supraoptic vasopressin neurones following systemic clonidine
41. Clonidine decreases plasma and cerebrospinal fluid arginine vasopressin but not oxytocin in humans
42. Pituitary-brain vascular relations: A new paradigm
43. Mechanism of restoration of ACTH release in rats with long-term lesions of the paraventricular nucleus
44. Corticotrophin-releasing peptides in rat hypophysial portal blood after paraventricular lesions: A marked reduction in the concentration of corticotrophin-releasing factor-41, but no change in vasopressin
45. Selective inhibition of magnocellular vasopressin neurons by hypoosmolality: Effect on histamine- and stress-induced secretion of adrenocorticotropin and prolactin
46. ACTH and corticosterone secretion in rats following removal of the neurointermediate lobe of the pituitary gland
47. Augmentation of the response to CRF in man: Relative contributions of endogenous angiotensin and vasopressin
48. Factors affecting ACTH released from perifused equine anterior pituitary cells
49. Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro
50. Blockade of alpha 2-adrenoceptors stimulates basal and stress-induced adrenocorticotropin secretion in the developing rat through a central mechanism independent from corticotrophin-releasing factor and arginine vasopressin
51. The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses